The global NAD+ Intravenous Injection Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.

NAD+ Intravenous Injection Therapy Market

NAD+ intravenous injection therapy is an anti-aging and energy metabolism intervention therapy that delivers nicotinamide adenine dinucleotide (NAD+) directly into the bloodstream via intravenous injection. NAD+ is a key intracellular coenzyme involved in energy production, DNA repair, antioxidation, and metabolic regulation. Through intravenous injection, NAD+ concentrations in the body can be rapidly increased, promoting cell vitality and metabolism, thereby improving fatigue, cognitive function, and sleep quality, and potentially delaying aging and assisting in the treatment of chronic diseases. The upstream mainly involves NAD+ raw material manufacturers, pharmaceutical raw material suppliers, and injectable formulation manufacturers; the downstream targets medical aesthetic institutions, anti-aging clinics, rehabilitation centers, and high-end health management service providers. With the increasing demand for health management and precision medicine, NAD+ intravenous injection therapy is gradually becoming a popular project for high-end anti-aging and functional health interventions.

1. Classification by Clinical Purpose (Indication-Oriented Classification)

From a clinical perspective, NAD⁺ IV therapy can be classified according to its primary medical or functional objectives, including anti-fatigue and energy enhancement therapy, neurocognitive support therapy, metabolic and mitochondrial optimization therapy, and stress recovery or burnout management therapy. This classification reflects how NAD⁺ IV is positioned in functional medicine and longevity clinics, where different patient groups are targeted based on symptom profiles rather than disease diagnoses, and where therapy is framed as a systemic cellular support intervention.

2. Classification by Medical Context (Service Setting Classification)

Based on the delivery environment and level of medical integration, NAD⁺ IV therapy can be divided into hospital-based medical therapy, functional medicine clinic therapy, and wellness or medical spa therapy. Hospital-based applications typically emphasize clinical safety, monitoring, and integration with other medical treatments, while functional medicine clinics focus on preventive health and personalized optimization. Wellness and medical spa settings position NAD⁺ IV more as a lifestyle or rejuvenation service, usually with lower regulatory thresholds and higher marketing orientation.

3. Classification by Formulation Type (Product/Formulation Classification)

From a pharmaceutical and technical standpoint, NAD⁺ IV therapy can be classified into pure NAD⁺ formulations, NAD⁺ combined formulations (co-infused with vitamins, amino acids, or antioxidants), and NAD-related formulations using NAD⁺ precursors or analogs. This classification highlights the heterogeneity of products in the market and reflects differences in pharmacological positioning, cost structure, stability, and claimed functional benefits.

4. Classification by Delivery Protocol (Administration and Treatment Regimen)

According to treatment protocols and infusion strategies, NAD⁺ IV therapy can be categorized into high-dose continuous infusion, low-dose maintenance infusion, and personalized adaptive infusion protocols. Different clinics adopt different infusion speeds, total dosage, and treatment cycles, depending on patient tolerance, therapeutic goals, and clinical philosophy, which directly influences both patient experience and operational cost.

5. Classification by Commercial Model (Business Model Classification)

From a business and market perspective, NAD⁺ IV therapy can be classified into single-session therapeutic services, multi-session package programs, and integrated longevity management programs. The first focuses on episodic revenue from individual treatments, the second emphasizes customer retention through bundled packages, while the third embeds NAD⁺ IV into long-term health management systems with diagnostics, monitoring, and personalized medical services.

This report delivers a comprehensive overview of the global NAD+ Intravenous Injection Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NAD+ Intravenous Injection Therapy. The NAD+ Intravenous Injection Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global NAD+ Intravenous Injection Therapy market comprehensively. Regional market sizes by Type, by Application, by Period, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist NAD+ Intravenous Injection Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of NAD+ Intravenous Injection Therapy Market Report

Report Metric	Details
Report Name	NAD+ Intravenous Injection Therapy Market
Accounted market size in 2025	US$ 99 million
Forecasted market size in 2032	US$ 171 million
CAGR	8.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	NAD+ Vitamin Mix Injection Pure NAD+ Injection
Segment by Period	Single-use Injection Type Recurring Injection Type Other
Segment by Dose	Low-dose Type Medium-dose Type High-dose Type
Segment by Application	Clinic Hospital Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Premiumhealth, Effect Doctors, Nadclinic, Hydrate IV Bar, LIVV Natural, BioReset Medical, IV Boost UK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Period, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for NAD+ Intravenous Injection Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is NAD+ Intravenous Injection Therapy Market growing?

Ans: The NAD+ Intravenous Injection Therapy Market witnessing a CAGR of 8.3% during the forecast period 2026-2032.

What is the NAD+ Intravenous Injection Therapy Market size in 2032?

Ans: The NAD+ Intravenous Injection Therapy Market size in 2032 will be US$ 171 million.

Who are the main players in the NAD+ Intravenous Injection Therapy Market report?

Ans: The main players in the NAD+ Intravenous Injection Therapy Market are The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Premiumhealth, Effect Doctors, Nadclinic, Hydrate IV Bar, LIVV Natural, BioReset Medical, IV Boost UK

What are the Application segmentation covered in the NAD+ Intravenous Injection Therapy Market report?

Ans: The Applications covered in the NAD+ Intravenous Injection Therapy Market report are Clinic, Hospital, Other

What are the Type segmentation covered in the NAD+ Intravenous Injection Therapy Market report?

Ans: The Types covered in the NAD+ Intravenous Injection Therapy Market report are NAD+ Vitamin Mix Injection, Pure NAD+ Injection

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NAD+ Intravenous Injection Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 NAD+ Vitamin Mix Injection

1.2.3 Pure NAD+ Injection

1.3 Market by Period

1.3.1 Global NAD+ Intravenous Injection Therapy Market Size Growth Rate by Period: 2021 vs 2025 vs 2032

1.3.2 Single-use Injection Type

1.3.3 Recurring Injection Type

1.3.4 Other

1.4 Market by Dose

1.4.1 Global NAD+ Intravenous Injection Therapy Market Size Growth Rate by Dose: 2021 vs 2025 vs 2032

1.4.2 Low-dose Type

1.4.3 Medium-dose Type

1.4.4 High-dose Type

1.5 Market by Application

1.5.1 Global NAD+ Intravenous Injection Therapy Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Clinic

1.5.3 Hospital

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global NAD+ Intravenous Injection Therapy Market Perspective (2021–2032)

2.2 Global NAD+ Intravenous Injection Therapy Growth Trends by Region

2.2.1 Global NAD+ Intravenous Injection Therapy Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 NAD+ Intravenous Injection Therapy Historic Market Size by Region (2021–2026)

2.2.3 NAD+ Intravenous Injection Therapy Forecasted Market Size by Region (2027–2032)

2.3 NAD+ Intravenous Injection Therapy Market Dynamics

2.3.1 NAD+ Intravenous Injection Therapy Industry Trends

2.3.2 NAD+ Intravenous Injection Therapy Market Drivers

2.3.3 NAD+ Intravenous Injection Therapy Market Challenges

2.3.4 NAD+ Intravenous Injection Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NAD+ Intravenous Injection Therapy Players by Revenue

3.1.1 Global Top NAD+ Intravenous Injection Therapy Players by Revenue (2021–2026)

3.1.2 Global NAD+ Intravenous Injection Therapy Revenue Market Share by Players (2021–2026)

3.2 Global Top NAD+ Intravenous Injection Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by NAD+ Intravenous Injection Therapy Revenue

3.4 Global NAD+ Intravenous Injection Therapy Market Concentration Ratio

3.4.1 Global NAD+ Intravenous Injection Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NAD+ Intravenous Injection Therapy Revenue in 2025

3.5 Global Key Players of NAD+ Intravenous Injection Therapy Head Offices and Areas Served

3.6 Global Key Players of NAD+ Intravenous Injection Therapy, Products and Applications

3.7 Global Key Players of NAD+ Intravenous Injection Therapy, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 NAD+ Intravenous Injection Therapy Breakdown Data by Type

4.1 Global NAD+ Intravenous Injection Therapy Historic Market Size by Type (2021–2026)

4.2 Global NAD+ Intravenous Injection Therapy Forecasted Market Size by Type (2027–2032)

5 NAD+ Intravenous Injection Therapy Breakdown Data by Application

5.1 Global NAD+ Intravenous Injection Therapy Historic Market Size by Application (2021–2026)

5.2 Global NAD+ Intravenous Injection Therapy Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America NAD+ Intravenous Injection Therapy Market Size (2021–2032)

6.2 North America NAD+ Intravenous Injection Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America NAD+ Intravenous Injection Therapy Market Size by Country (2021–2026)

6.4 North America NAD+ Intravenous Injection Therapy Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NAD+ Intravenous Injection Therapy Market Size (2021–2032)

7.2 Europe NAD+ Intravenous Injection Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe NAD+ Intravenous Injection Therapy Market Size by Country (2021–2026)

7.4 Europe NAD+ Intravenous Injection Therapy Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific NAD+ Intravenous Injection Therapy Market Size (2021–2032)

8.2 Asia-Pacific NAD+ Intravenous Injection Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific NAD+ Intravenous Injection Therapy Market Size by Region (2021–2026)

8.4 Asia-Pacific NAD+ Intravenous Injection Therapy Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America NAD+ Intravenous Injection Therapy Market Size (2021–2032)

9.2 Latin America NAD+ Intravenous Injection Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America NAD+ Intravenous Injection Therapy Market Size by Country (2021–2026)

9.4 Latin America NAD+ Intravenous Injection Therapy Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NAD+ Intravenous Injection Therapy Market Size (2021–2032)

10.2 Middle East & Africa NAD+ Intravenous Injection Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa NAD+ Intravenous Injection Therapy Market Size by Country (2021–2026)

10.4 Middle East & Africa NAD+ Intravenous Injection Therapy Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 The Wellness Lab

11.1.1 The Wellness Lab Company Details

11.1.2 The Wellness Lab Business Overview

11.1.3 The Wellness Lab NAD+ Intravenous Injection Therapy Introduction

11.1.4 The Wellness Lab Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.1.5 The Wellness Lab Recent Development

11.2 Conciergemdla

11.2.1 Conciergemdla Company Details

11.2.2 Conciergemdla Business Overview

11.2.3 Conciergemdla NAD+ Intravenous Injection Therapy Introduction

11.2.4 Conciergemdla Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.2.5 Conciergemdla Recent Development

11.3 Azivmedics

11.3.1 Azivmedics Company Details

11.3.2 Azivmedics Business Overview

11.3.3 Azivmedics NAD+ Intravenous Injection Therapy Introduction

11.3.4 Azivmedics Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.3.5 Azivmedics Recent Development

11.4 Reset IV

11.4.1 Reset IV Company Details

11.4.2 Reset IV Business Overview

11.4.3 Reset IV NAD+ Intravenous Injection Therapy Introduction

11.4.4 Reset IV Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.4.5 Reset IV Recent Development

11.5 Thedripclub

11.5.1 Thedripclub Company Details

11.5.2 Thedripclub Business Overview

11.5.3 Thedripclub NAD+ Intravenous Injection Therapy Introduction

11.5.4 Thedripclub Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.5.5 Thedripclub Recent Development

11.6 Toronto Functional Medicine Centre

11.6.1 Toronto Functional Medicine Centre Company Details

11.6.2 Toronto Functional Medicine Centre Business Overview

11.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Injection Therapy Introduction

11.6.4 Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.6.5 Toronto Functional Medicine Centre Recent Development

11.7 Mobileivmedics

11.7.1 Mobileivmedics Company Details

11.7.2 Mobileivmedics Business Overview

11.7.3 Mobileivmedics NAD+ Intravenous Injection Therapy Introduction

11.7.4 Mobileivmedics Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.7.5 Mobileivmedics Recent Development

11.8 Rocky Mountain Ivmedics

11.8.1 Rocky Mountain Ivmedics Company Details

11.8.2 Rocky Mountain Ivmedics Business Overview

11.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Injection Therapy Introduction

11.8.4 Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.8.5 Rocky Mountain Ivmedics Recent Development

11.9 Premiumhealth

11.9.1 Premiumhealth Company Details

11.9.2 Premiumhealth Business Overview

11.9.3 Premiumhealth NAD+ Intravenous Injection Therapy Introduction

11.9.4 Premiumhealth Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.9.5 Premiumhealth Recent Development

11.10 Effect Doctors

11.10.1 Effect Doctors Company Details

11.10.2 Effect Doctors Business Overview

11.10.3 Effect Doctors NAD+ Intravenous Injection Therapy Introduction

11.10.4 Effect Doctors Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.10.5 Effect Doctors Recent Development

11.11 Nadclinic

11.11.1 Nadclinic Company Details

11.11.2 Nadclinic Business Overview

11.11.3 Nadclinic NAD+ Intravenous Injection Therapy Introduction

11.11.4 Nadclinic Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.11.5 Nadclinic Recent Development

11.12 Hydrate IV Bar

11.12.1 Hydrate IV Bar Company Details

11.12.2 Hydrate IV Bar Business Overview

11.12.3 Hydrate IV Bar NAD+ Intravenous Injection Therapy Introduction

11.12.4 Hydrate IV Bar Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.12.5 Hydrate IV Bar Recent Development

11.13 LIVV Natural

11.13.1 LIVV Natural Company Details

11.13.2 LIVV Natural Business Overview

11.13.3 LIVV Natural NAD+ Intravenous Injection Therapy Introduction

11.13.4 LIVV Natural Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.13.5 LIVV Natural Recent Development

11.14 BioReset Medical

11.14.1 BioReset Medical Company Details

11.14.2 BioReset Medical Business Overview

11.14.3 BioReset Medical NAD+ Intravenous Injection Therapy Introduction

11.14.4 BioReset Medical Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.14.5 BioReset Medical Recent Development

11.15 IV Boost UK

11.15.1 IV Boost UK Company Details

11.15.2 IV Boost UK Business Overview

11.15.3 IV Boost UK NAD+ Intravenous Injection Therapy Introduction

11.15.4 IV Boost UK Revenue in NAD+ Intravenous Injection Therapy Business (2021–2026)

11.15.5 IV Boost UK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Toronto Functional Medicine Centre

Mobileivmedics

Rocky Mountain Ivmedics

List of Tables

Table 1. Global NAD+ Intravenous Injection Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of NAD+ Vitamin Mix Injection

Table 3. Key Players of Pure NAD+ Injection

Table 4. Global NAD+ Intravenous Injection Therapy Market Size Growth Rate by Period (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Single-use Injection Type

Table 6. Key Players of Recurring Injection Type

Table 7. Key Players of Other

Table 8. Global NAD+ Intravenous Injection Therapy Market Size Growth Rate by Dose (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Low-dose Type

Table 10. Key Players of Medium-dose Type

Table 11. Key Players of High-dose Type

Table 12. Global NAD+ Intravenous Injection Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 13. Global NAD+ Intravenous Injection Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global NAD+ Intravenous Injection Therapy Market Size by Region (US$ Million), 2021–2026

Table 15. Global NAD+ Intravenous Injection Therapy Market Share by Region (2021–2026)

Table 16. Global NAD+ Intravenous Injection Therapy Forecasted Market Size by Region (US$ Million), 2027–2032

Table 17. Global NAD+ Intravenous Injection Therapy Market Share by Region (2027–2032)

Table 18. NAD+ Intravenous Injection Therapy Market Trends

Table 19. NAD+ Intravenous Injection Therapy Market Drivers

Table 20. NAD+ Intravenous Injection Therapy Market Challenges

Table 21. NAD+ Intravenous Injection Therapy Market Restraints

Table 22. Global NAD+ Intravenous Injection Therapy Revenue by Players (US$ Million), 2021–2026

Table 23. Global NAD+ Intravenous Injection Therapy Market Share by Players (2021–2026)

Table 24. Global Top NAD+ Intravenous Injection Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on NAD+ Intravenous Injection Therapy Revenue, 2025

Table 25. Ranking of Global Top NAD+ Intravenous Injection Therapy Companies by Revenue (US$ Million) in 2025

Table 26. Global 5 Largest Players Market Share by NAD+ Intravenous Injection Therapy Revenue (CR5 and HHI), 2021–2026

Table 27. Global Key Players of NAD+ Intravenous Injection Therapy, Headquarters and Area Served

Table 28. Global Key Players of NAD+ Intravenous Injection Therapy, Products and Applications

Table 29. Global Key Players of NAD+ Intravenous Injection Therapy, Date of General Availability (GA)

Table 30. Mergers and Acquisitions, Expansion Plans

Table 31. Global NAD+ Intravenous Injection Therapy Market Size by Type (US$ Million), 2021–2026

Table 32. Global NAD+ Intravenous Injection Therapy Revenue Market Share by Type (2021–2026)

Table 33. Global NAD+ Intravenous Injection Therapy Forecasted Market Size by Type (US$ Million), 2027–2032

Table 34. Global NAD+ Intravenous Injection Therapy Revenue Market Share by Type (2027–2032)

Table 35. Global NAD+ Intravenous Injection Therapy Market Size by Application (US$ Million), 2021–2026

Table 36. Global NAD+ Intravenous Injection Therapy Revenue Market Share by Application (2021–2026)

Table 37. Global NAD+ Intravenous Injection Therapy Forecasted Market Size by Application (US$ Million), 2027–2032

Table 38. Global NAD+ Intravenous Injection Therapy Revenue Market Share by Application (2027–2032)

Table 39. North America NAD+ Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. North America NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2021–2026

Table 41. North America NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2027–2032

Table 42. Europe NAD+ Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Europe NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2021–2026

Table 44. Europe NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2027–2032

Table 45. Asia-Pacific NAD+ Intravenous Injection Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 46. Asia-Pacific NAD+ Intravenous Injection Therapy Market Size by Region (US$ Million), 2021–2026

Table 47. Asia-Pacific NAD+ Intravenous Injection Therapy Market Size by Region (US$ Million), 2027–2032

Table 48. Latin America NAD+ Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Latin America NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2021–2026

Table 50. Latin America NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2027–2032

Table 51. Middle East & Africa NAD+ Intravenous Injection Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Middle East & Africa NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2021–2026

Table 53. Middle East & Africa NAD+ Intravenous Injection Therapy Market Size by Country (US$ Million), 2027–2032

Table 54. The Wellness Lab Company Details

Table 55. The Wellness Lab Business Overview

Table 56. The Wellness Lab NAD+ Intravenous Injection Therapy Product

Table 57. The Wellness Lab Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 58. The Wellness Lab Recent Development

Table 59. Conciergemdla Company Details

Table 60. Conciergemdla Business Overview

Table 61. Conciergemdla NAD+ Intravenous Injection Therapy Product

Table 62. Conciergemdla Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 63. Conciergemdla Recent Development

Table 64. Azivmedics Company Details

Table 65. Azivmedics Business Overview

Table 66. Azivmedics NAD+ Intravenous Injection Therapy Product

Table 67. Azivmedics Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 68. Azivmedics Recent Development

Table 69. Reset IV Company Details

Table 70. Reset IV Business Overview

Table 71. Reset IV NAD+ Intravenous Injection Therapy Product

Table 72. Reset IV Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 73. Reset IV Recent Development

Table 74. Thedripclub Company Details

Table 75. Thedripclub Business Overview

Table 76. Thedripclub NAD+ Intravenous Injection Therapy Product

Table 77. Thedripclub Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 78. Thedripclub Recent Development

Table 79. Toronto Functional Medicine Centre Company Details

Table 80. Toronto Functional Medicine Centre Business Overview

Table 81. Toronto Functional Medicine Centre NAD+ Intravenous Injection Therapy Product

Table 82. Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 83. Toronto Functional Medicine Centre Recent Development

Table 84. Mobileivmedics Company Details

Table 85. Mobileivmedics Business Overview

Table 86. Mobileivmedics NAD+ Intravenous Injection Therapy Product

Table 87. Mobileivmedics Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 88. Mobileivmedics Recent Development

Table 89. Rocky Mountain Ivmedics Company Details

Table 90. Rocky Mountain Ivmedics Business Overview

Table 91. Rocky Mountain Ivmedics NAD+ Intravenous Injection Therapy Product

Table 92. Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 93. Rocky Mountain Ivmedics Recent Development

Table 94. Premiumhealth Company Details

Table 95. Premiumhealth Business Overview

Table 96. Premiumhealth NAD+ Intravenous Injection Therapy Product

Table 97. Premiumhealth Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 98. Premiumhealth Recent Development

Table 99. Effect Doctors Company Details

Table 100. Effect Doctors Business Overview

Table 101. Effect Doctors NAD+ Intravenous Injection Therapy Product

Table 102. Effect Doctors Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 103. Effect Doctors Recent Development

Table 104. Nadclinic Company Details

Table 105. Nadclinic Business Overview

Table 106. Nadclinic NAD+ Intravenous Injection Therapy Product

Table 107. Nadclinic Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 108. Nadclinic Recent Development

Table 109. Hydrate IV Bar Company Details

Table 110. Hydrate IV Bar Business Overview

Table 111. Hydrate IV Bar NAD+ Intravenous Injection Therapy Product

Table 112. Hydrate IV Bar Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 113. Hydrate IV Bar Recent Development

Table 114. LIVV Natural Company Details

Table 115. LIVV Natural Business Overview

Table 116. LIVV Natural NAD+ Intravenous Injection Therapy Product

Table 117. LIVV Natural Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 118. LIVV Natural Recent Development

Table 119. BioReset Medical Company Details

Table 120. BioReset Medical Business Overview

Table 121. BioReset Medical NAD+ Intravenous Injection Therapy Product

Table 122. BioReset Medical Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 123. BioReset Medical Recent Development

Table 124. IV Boost UK Company Details

Table 125. IV Boost UK Business Overview

Table 126. IV Boost UK NAD+ Intravenous Injection Therapy Product

Table 127. IV Boost UK Revenue in NAD+ Intravenous Injection Therapy Business (US$ Million), 2021–2026

Table 128. IV Boost UK Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

Table 132. Authors List of This Report

List of Figures

Figure 1. NAD+ Intravenous Injection Therapy Picture

Figure 2. Global NAD+ Intravenous Injection Therapy Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global NAD+ Intravenous Injection Therapy Market Share by Type: 2025 vs 2032

Figure 4. NAD+ Vitamin Mix Injection Features

Figure 5. Pure NAD+ Injection Features

Figure 6. Global NAD+ Intravenous Injection Therapy Market Size Comparison by Period (US$ Million), 2021–2032

Figure 7. Single-use Injection Type Features

Figure 8. Recurring Injection Type Features

Figure 9. Other Features

Figure 10. Global NAD+ Intravenous Injection Therapy Market Size Comparison by Dose (US$ Million), 2021–2032

Figure 11. Low-dose Type Features

Figure 12. Medium-dose Type Features

Figure 13. High-dose Type Features

Figure 14. Global NAD+ Intravenous Injection Therapy Market Size by Application (US$ Million), 2021–2032

Figure 15. Global NAD+ Intravenous Injection Therapy Market Share by Application: 2025 vs 2032

Figure 16. Clinic Case Studies

Figure 17. Hospital Case Studies

Figure 18. Other Case Studies

Figure 19. NAD+ Intravenous Injection Therapy Report Years Considered

Figure 20. Global NAD+ Intravenous Injection Therapy Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 21. Global NAD+ Intravenous Injection Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global NAD+ Intravenous Injection Therapy Market Share by Region: 2025 vs 2032

Figure 23. Global NAD+ Intravenous Injection Therapy Market Share by Players in 2025

Figure 24. Global NAD+ Intravenous Injection Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 25. The Top 10 and 5 Players Market Share by NAD+ Intravenous Injection Therapy Revenue in 2025

Figure 26. North America NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. North America NAD+ Intravenous Injection Therapy Market Share by Country (2021–2032)

Figure 28. United States NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Canada NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Europe NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe NAD+ Intravenous Injection Therapy Market Share by Country (2021–2032)

Figure 32. Germany NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. France NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. U.K. NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Italy NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Russia NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Ireland NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Asia-Pacific NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific NAD+ Intravenous Injection Therapy Market Share by Region (2021–2032)

Figure 40. China NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Japan NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. South Korea NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Southeast Asia NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. India NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Australia & New Zealand NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Latin America NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America NAD+ Intravenous Injection Therapy Market Share by Country (2021–2032)

Figure 48. Mexico NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Brazil NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Middle East & Africa NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa NAD+ Intravenous Injection Therapy Market Share by Country (2021–2032)

Figure 52. Israel NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Saudi Arabia NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. UAE NAD+ Intravenous Injection Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. The Wellness Lab Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 56. Conciergemdla Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 57. Azivmedics Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 58. Reset IV Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 59. Thedripclub Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 60. Toronto Functional Medicine Centre Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 61. Mobileivmedics Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 62. Rocky Mountain Ivmedics Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 63. Premiumhealth Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 64. Effect Doctors Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 65. Nadclinic Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 66. Hydrate IV Bar Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 67. LIVV Natural Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 68. BioReset Medical Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 69. IV Boost UK Revenue Growth Rate in NAD+ Intravenous Injection Therapy Business (2021–2026)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions